Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...